We are live on ! Find out more
ICM

Invenomic Capital Management Portfolio holdings

AUM $2.18B
1-Year Est. Return 0.03%
This Fund
S&P 500
This Quarter Est. Return
-3.04%
1 Year Est. Return
+0.03%
3 Year Est. Return
-6.37%
5 Year Est. Return
-25.27%
10 Year Est. Return
AUM
$2.1B
AUM Growth
+$282M
Cap. Flow
+$321M
Cap. Flow %
15.28%
Top 10 Hldgs %
31.03%
Holding
185
New
43
Increased
48
Reduced
68
Closed
26

Top Buys

Rank Stock Value
1
XRAY icon
Dentsply Sirona
XRAY
+$37.3M
2
SON icon
Sonoco
SON
+$27.1M
3
MTCH icon
Match Group
MTCH
+$24.8M
4
PLD icon
Prologis
PLD
+$23.9M
5
SLB icon
SLB Ltd
SLB
+$19.3M

Top Sells

Rank Stock Value
1
MTB icon
M&T Bank
MTB
+$36.8M
2
ZM icon
Zoom
ZM
+$25.3M
3
WBD icon
Warner Bros
WBD
+$23.6M
4
LYFT icon
Lyft
LYFT
+$22.3M
5
EXPE icon
Expedia Group
EXPE
+$20.5M

Sector Composition

Rank Sector Weight
1 Technology 18.46%
2 Consumer Discretionary 13.65%
3 Healthcare 10.33%
4 Communication Services 7.49%
5 Consumer Staples 7.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NVST icon
176
Envista
NVST
$4.53B
-293,188
Closed -$5.79M
REZI icon
177
Resideo Technologies
REZI
$3.67B
-271,826
Closed -$5.47M
ROG icon
178
Rogers Corp
ROG
$2.29B
-27,053
Closed -$3.06M
RPD icon
179
Rapid7
RPD
$776M
-166,629
Closed -$6.65M
SEDG icon
180
SolarEdge
SEDG
$1.98B
-370,577
Closed -$8.49M
TRS icon
181
TriMas Corp
TRS
$1.43B
-143,152
Closed -$3.65M
U icon
182
Unity
U
$19B
-208,371
Closed -$4.71M
WBD icon
183
Warner Bros
WBD
$67.4B
-2,865,199
Closed -$23.6M
WOOF icon
184
Petco
WOOF
$765M
-603,635
Closed -$2.75M
EXE
185
Expand Energy Corp
EXE
$22.6B
-154,893
Closed -$12.7M

Similar funds

Invenomic Capital Management's Q4 2024 Portfolio in Review

As of Q4 2024, Invenomic Capital Management held 185 positions worth $2.1B, up 15% from $1.82B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Invenomic Capital Management deployed $321M of net new capital in Q4 2024, opening 43 new positions and adding to 48 existing holdings. Its largest new stake was Prologis: 207,979 shares worth $22M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 23% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was M&T Bank, an estimated $36.8M trimmed.

  • Invenomic Capital Management's largest Q4 2024 buy was Prologis: 207,979 shares worth $22M.
  • Invenomic Capital Management added most to Dentsply Sirona in Q4 2024, an estimated $37.3M increase.
  • Invenomic Capital Management's biggest Q4 2024 reduction was M&T Bank, cutting an estimated $36.8M.
  • Invenomic Capital Management fully exited Warner Bros in Q4 2024, selling an estimated $23.6M.
  • Invenomic Capital Management's ten largest holdings make up 31% of its $2.1B portfolio in Q4 2024.
  • Invenomic Capital Management opened 43 new positions and closed 26 in Q4 2024.
  • Invenomic Capital Management's portfolio value rose 15% quarter-over-quarter to $2.1B.

Based on Invenomic Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.